Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T16:34:09.337Z.
Calculation as of: 2026-10-06T16:34:09.337Z.
Quote observation: 2026-10-06T16:30:41.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 09a0ab09da9db255713b3d52bc1d4f6ff3c974c87d2899d50b33d975ee1631b8
PE RATIO
N/A
Prelude Therapeutics Incorporated
Market Cap
$214.35M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$218.36M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Prelude Therapeutics Incorporated (PRLD) | $214.35M | N/A | N/A | N/A | N/A |
| Niagen Bioscience Inc (NAGE)vs › | $214.39M | 14.44 | 22.48 | 68.28 | 68.28 |
| Compugen Ltd. (CGEN)vs › | $211.80M | 5.97 | 6.53 | 42.60 | 42.60 |
| Alector, Inc. (ALEC)vs › | $216.72M | N/A | 25.58 | 25.58 | 25.58 |
| Lyell Immunopharma, Inc. (LYEL)vs › | $218.09M | N/A | N/A | N/A | N/A |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $218.36M | N/A | N/A | N/A | N/A |
| Sionna Therapeutics, Inc. (SION)vs › | $209.27M | N/A | N/A | N/A | N/A |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $208.90M | N/A | 5.74 | 5.74 | 5.74 |
| Keros Therapeutics, Inc. (KROS)vs › | $221.27M | N/A | 26.24 | 26.24 | 26.24 |
| Pro-Dex, Inc. (PDEX)vs › | $206.63M | 15.71 | 14.32 | 17.96 | 17.40 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$3.77
Forward EPS (Est.)
$-0.78
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
